We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This playbook explains how we use social media at GDS. In it, we share our best practice, what we've learned and what we're planning to do.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Find woodland agreements, felling licences and other designations or features on any chosen area of land in England.
This guidance aims to help people develop and manage communities of practice across government.
Provides advice on the key points to take into account on design.
Find out how new woodland can enhance landscape character as well as a wide range of benefits to the woodland owner and society.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
The shape and the configuration of objects are automatically protected by design right in the UK and Europe.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Practical steps to manage the risk of online harms if your online platform makes users’ account details and activity visible to others.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Practical steps to manage the risk of online harm if your online platform allows people to interact, and to share text and other content.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to use an N-of-1 study to evaluate your digital health product.
Use a reference architecture to develop a public sector organisation’s technology and how it shares data across government.
How investigators and sponsors should manage clinical trials during COVID-19
Submissions related to human medicines need to be submitted directly to the MHRA.
How to use a case-control study to evaluate your digital health product.
How to use usability testing to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.